Cold Pain Therapy Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cold Pain Therapy Market size was valued at around USD 1.9 billion in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. The increasing prevalence of orthopedic diseases significantly contributes to the growth of the market. With the rise in conditions such as osteoarthritis, rheumatoid arthritis, and sports injuries, there is a growing need for effective, non-invasive pain management solutions.
For instance, according to the Centers for Disease Control and Prevention (CDC), 23% of all adults in the U.S. have arthritis, which equates to more than 54 million people. The prevalence of osteoarthritis is expected to increase with the aging population. Cold pain therapy meets this demand, providing relief and supporting recovery, which drives market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Cold Pain Therapy Market size in 2023: | USD 1.9 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2023 - 2032 CAGR: | 4.8 |
2023 Value Projection: | USD 3 Billion |
Historical Data for: | 2021 - 2023 |
No of Pages: | 100 |
Tables, Charts & Figures: | 177 |
Segments Covered: | Product Type, Application, Distribution Channel and Region |
Growth Drivers: |
|
Pitfalls Challenges: |
|
Cold pain therapy is a treatment method that involves the application of cold substances or devices to the body to reduce pain, inflammation, and swelling. It is commonly used for acute injuries, chronic pain, and post-surgical recovery. The therapy works by constricting blood vessels, which decreases blood flow to the affected area, thereby reducing inflammation and numbing nerve endings to alleviate pain.
The demand for safer pain management modalities is driving the growth of the cold pain therapy industry, as patients and healthcare providers increasingly seek alternatives to traditional methods.
Based on disease type, the market is categorized into OTC products and prescription products. The OTC products segment dominated the market, with a revenue share of around 72.6% in 2023.
Based on application, the cold pain therapy market is categorized into musculoskeletal disorders, post-operative therapy, sports injuries and post-trauma therapy. The musculoskeletal disorders segment dominated the market with USD 777.4 million in 2023.
Based on distribution channel, the cold pain therapy market is categorized into brick and mortar and E-commerce. The brick and mortar segment dominated the market, with a revenue share of around 71.2% in 2023.
North America cold pain therapy market accounted for USD 676.2 million revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
U.S. cold pain therapy market held a dominant position with the market share of 92.6% in 2023.
Germany cold pain therapy market is expected to grow significantly during the forecast period.
China cold pain therapy market is anticipated to witness a high growth rate from 2024-2032, due to several factors.
The cold pain therapy industry is competitive in nature, with various large multinationals, small and mid-sized companies competing in the industry. The development and launch of novel therapeutics with improved efficiency and cost-effectiveness are key market strategies for cold pain therapeutic product manufacturers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance patient outcomes, positioning companies to gain market share and meet the growing demand for novel cold pain therapy.
Some of the eminent market participants operating in the cold pain therapy industry include:
Market, By Product Type
Market, By Application
Market, By Distribution Channel
The above information is provided for the following regions and countries:
Bird & Cronin, LLC, Breg, Inc., Cardinal Health, Compass Health Brands, Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Consumer Inc., Performance Health, Polar Products Inc., Rapid Aid, Romsons Group of Industries, and Sanofi among others.
North America cold pain therapy industry size was USD 676.2 million in 2023, propelled by the high prevalence of sports injuries and musculoskeletal disorders, advanced healthcare infrastructure, coupled with significant investments in R&D of innovative cold therapy products.
The musculoskeletal disorders segment recorded USD 777.4 million in 2023, primarily due to the high prevalence of conditions like arthritis, back pain, and tendonitis and increasing awareness of the benefits in reducing inflammation and accelerating recovery.
Cold pain therapy industry size was worth USD 1.9 billion in 2023 and will grow at 4.8% CAGR between 2024 and 2032, driven by the rising prevalence of sports injuries and musculoskeletal disorders along with the increasing demand for effective pain management solutions.